HER2-low Unresectable and/or Metastatic Breast Cancer in Russia
Clinical trial NCT05913440 · COMPLETED
Trial details
- NCT number
- NCT05913440
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-30
- Primary completion
- 2025-03-14
- Enrollment
- 1669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.